GILEAD SCIENCES INC (GILD:NASDAQ)
$130.95 -3.48 (-2.5887%)
Analysed GILEAD SCIENCES INC (GILD:NASDAQ) News Sources
3 Stocks Estimated To Be Trading Up To 44.8% Below Intrinsic Value
26-05-2026
yahoo.com
FDA accelerated approval of Hepcludex significant milestone for US HDV market
28-05-2026
clinicaltrialsarena.com
Novel Spanish, Culturally Adapted Metastatic Breast Cancer Symptom Management Guide Debuts at ASCO 2026
28-05-2026
yahoo.com
S&P 500, Nasdaq Rise to Another Record. Software Strikes Back.
28-05-2026
yahoo.com
Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex
29-05-2026
yahoo.com
Allogene CEO to step down; Agios drug fails key test
29-05-2026
biopharmadive.com
Discover May 2026's Stocks That Could Be Trading Below Estimated Value
29-05-2026
yahoo.com
Three Stocks That May Be Trading Below Estimated Value In May 2026
29-05-2026
yahoo.com
Natera And 2 Other Companies That May Be Trading Below Their Estimated Value
01-06-2026
yahoo.com
Gilead (GILD) to Showcase New Cancer Therapy Data
01-06-2026
yahoo.com
What is the current price of GILEAD SCIENCES INC (GILD:NASDAQ)?
The current price of GILEAD SCIENCES INC (GILD:NASDAQ) is $130.95.
GILEAD SCIENCES INC (GILD:NASDAQ) absolute price change since previous trading day?
The absolute price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is $-3.48.
GILEAD SCIENCES INC (GILD:NASDAQ) percentage price change since previous trading day?
The percentage price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is -2.5887%.
What is the most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent sentiment for GILEAD SCIENCES INC (GILD:NASDAQ) is .
SEC-8K** Filing Available For GILEAD SCIENCES INC (GILD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.